Jensen J C, Gugler R
Z Gastroenterol. 1987 Feb;25(2):112-8.
The inhibition of 7-ethoxycoumarin deethylase activity by four different H2-receptor antagonists was studied using rat liver microsomes. The compounds tested represent two classes of H2-antagonists, i. e. structures with (cimetidine and oxmetidine) and without (ranitidine and SKF 93479) an imidazole ring. The microsomes were prepared from untreated and phenobarbital-treated animals. It was found that all four compounds, even those without an imidazole ring, inhibited deethylase activity. The compounds inhibited in the following order: SKF 93479 (90%) greater than cimetidine (58%) = oxmetidine (58%) greater than ranitidine (23%). In microsomes from phenobarbital-induced animals, the inhibitory activity of oxmetidine was increased 5-fold. Only the inhibitory potency of cimetidine was increased by preincubation of the H2-antagonist with the microsomes prior to the addition of the substrate.
利用大鼠肝微粒体研究了四种不同的H2受体拮抗剂对7-乙氧基香豆素脱乙基酶活性的抑制作用。所测试的化合物代表两类H2拮抗剂,即具有(西咪替丁和奥米替丁)和不具有(雷尼替丁和SKF 93479)咪唑环的结构。微粒体取自未经处理和经苯巴比妥处理的动物。结果发现,所有四种化合物,甚至那些没有咪唑环的化合物,都能抑制脱乙基酶活性。这些化合物的抑制顺序如下:SKF 93479(90%)大于西咪替丁(58%)=奥米替丁(58%)大于雷尼替丁(23%)。在苯巴比妥诱导的动物的微粒体中,奥米替丁的抑制活性增加了5倍。只有在加入底物之前将H2拮抗剂与微粒体预孵育,西咪替丁的抑制效力才会增加。